Inventor · disambiguated record
Hédia Maamar
Also filed as: MAAMAR HEDIA · MAAMAR HÉDIA
13 granted patents·9 pending applications·61 citations·filing 2015–2023
89Inventor score
Top patents by PatentIndex Score
22 records- 0194US10820847B1Diagnostic systemTALIS BIOMEDICAL CORP·Filed 2019·Granted Nov 3, 2020·25 cites·30 claims
- 0291US10450616B1Polynucleotides for the amplification and detection of Chlamydia trachomatisTALIS BIOMEDICAL CORP·Filed 2018·Granted Oct 22, 2019·12 cites·27 claims
- 0389US11986299B2Diagnostic systemTALIS BIOMEDICAL CORP·Filed 2020·Granted May 21, 2024·2 cites·21 claims
- 0489US11047007B1Polynucleotides for amplification and detection of SARS-CoV-2TALIS BIOMEDICAL CORP·Filed 2020·Granted Jun 29, 2021·5 cites·9 claims
- 0587US11326214B2Polynucleotides for the amplification and detection of chlamydia trachomatisTALIS BIOMEDICAL CORP·Filed 2019·Granted May 10, 2022·4 cites·17 claims
- 0687US10252264B2Sample preparation module with stepwise pressurization mechanismSLIPCHIP CORP·Filed 2015·Granted Apr 9, 2019·8 cites·31 claims
- 0784US10954572B2Polynucleotides for the amplification and detection of Neisseria gonorrhoeaeTALIS BIOMEDICAL CORP·Filed 2019·Granted Mar 23, 2021·4 cites·27 claims
- 0883US11008627B2Diagnostic systemTALIS BIOMEDICAL CORP·Filed 2019·Granted May 18, 2021·1 cites·27 claims
- 0974US12310730B2Diagnostic systemTALIS BIOMEDICAL CORP·Filed 2021·Granted May 27, 2025·0 cites·28 claims
- 1073US11891662B2Polynucleotides for amplification and detection of human beta actinTALIS BIOMEDICAL CORP·Filed 2019·Granted Feb 6, 2024·0 cites·8 claims
- 1172US2022280081A1Diagnostic systemTALIS BIOMEDICAL CORP·Filed 2020·Application pending·0 cites
- 1272US2023073971A1Polynucleotides for the Amplification and Detection of Chlamydia TrachomatisTALIS BIOMEDICAL CORP·Filed 2022·Application pending·0 cites
- 1370US2024117447A1Polynucleotides for the amplification and detection of neisseria gonorrhoeaeTALIS BIOMEDICAL CORP·Filed 2023·Application pending·0 cites
- 1466US12264365B2Polynucleotides for amplification and detection of SARS-CoV-2TALIS BIOMEDICAL CORP·Filed 2020·Granted Apr 1, 2025·0 cites·24 claims
- 1566US2021301325A1Polynucleotides for the amplification and detection of chlamydia trachomatisTALIS BIOMEDICAL CORP·Filed 2019·Application pending·0 cites
- 1662US2023002826A1Polynucleotides for the amplification and detection of human beta actinTALIS BIOMEDICAL CORP·Filed 2020·Application pending·0 cites
- 1761US2021340622A1Polynucleotides for amplification and detection of sars-cov-2TALIS BIOMEDICAL CORP·Filed 2021·Application pending·0 cites
- 1855US2019284618A1Polynucleotides for the amplification and detection of neisseria gonorrhoeaeTALIS BIOMEDICAL CORP·Filed 2017·Application pending·0 cites
- 1950US12275999B2Polynucleotides for the amplification and detection of chlamydia trachomatisTALIS BIOMEDICAL CORP·Filed 2017·Granted Apr 15, 2025·0 cites·11 claims
- 2048US2024026465A9Polynucleotides for the amplification and detection of neisseria gonorrhoeaeTALIS BIOMEDICAL CORP·Filed 2020·Application pending·0 cites
- 2144US2021254139A1Probe detection of loop-mediated amplification productsTALIS BIOMEDICAL CORP·Filed 2017·Application pending·0 cites
- 2239US11542545B2Microfluidic measurements of the response of an organism to a drugCALIFORNIA INST OF TECHN·Filed 2015·Granted Jan 3, 2023·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Hédia Maamar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →